← FDA Drug Approvals (Drugs@FDA)

NEVIRAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LIMITED · Approved 2015-06-30

Drug application

FDA Application #

ANDA207064

Application type

Abbreviated New Drug Application (Generic)

Brand name

NEVIRAPINE

Generic name

Nevirapine

Active ingredients

NEVIRAPINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LIMITED

First approval

2015-06-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown